Charles River Laboratories (CRL) Tops Q2 EPS by 9c; Guides Higher
Tweet Send to a FriendGet Alerts CRL Hot Sheet
Price: $45.01 -0.27%
Revenue Growth %: +1.8%
Financial Fact:
Continuing operations (in dollars per share): 0.54
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: +1.8%
Financial Fact:
Continuing operations (in dollars per share): 0.54
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade CRL Now!
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $0.75, $0.09 better than the analyst estimate of $0.66. Revenue for the quarter came in at $284.7 million versus the consensus estimate of $286.16 million.
Charles River Laboratories sees FY2012 EPS of $2.63-$2.73, versus prior guidance of $2.60-$2.70 and the consensus of $2.69.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Charles River Laboratories sees FY2012 EPS of $2.63-$2.73, versus prior guidance of $2.60-$2.70 and the consensus of $2.69.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Leading Brands Inc New (LBIX) Reports Breakeven Q4 Loss
- Wal-mart (WMT) Posts Q1 EPS of $1.14; U.S. Comps Down 1.4%; Guides Q2 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
